Clinical Trial Update: Feasibility Study on the FARAVIEW Technology [NA]

View source ↗

Summary

Completed feasibility trial update on Boston Scientific's FARAVIEW technology for atrial fibrillation. The study included paroxysmal and persistent atrial fibri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Paroxysmal Atrial Fibrillation
• Persistent Atrial Fibrillation

Drugs mentioned

• FARAVIEW technology

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Atrial Fibrillation, Paroxysmal Atrial Fibrillation | NA | Status: COMPLETED